Private company

Vaxxinity, Inc.

American pharmaceutical preparations company based in Merritt Island. Summary from the record

Last updated Oct 19, 2026.

Overview

  • IndustryPharmaceutical Preparations2
  • HeadquartersMerritt Island, United States2
  • Incorporated inFL3
  • Business address505 Odyssey Way, Exploration Park, Fl 329533
  • Filer categoryNon-accelerated filer, Smaller reporting company, Emerging growth company3
  • Legal formCorporation2
  • LEI529900444BQJFC912P192
  • StatusActive2
  • LEI statusIssued and current2
  • Registered addressc/o CORPORATION SERVICE COMPANY,251 LITTLE FALLS DRIVE, 19808 Wilmington, United States2
  • Registered withDivision of Corporations, Department of State, 46334652

See how the biggest companies compare on our leaderboards

612 was well tolerated with balanced reactogenicity and no additional safety risks evoked over the licensed COVID-19 comparators.4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2022

-100.0%Revenue growth, 20225
-121.0%Return on equity6
-$57.8MFree cash flow6

Financial statements

Revenue75$0 in 2022
0$200.0K$400.0K$600.0K2020: $557.0K$557.0K20202021: $66.0K$66.0K2021−88%2022: $0$02022
Gross profit75$0 in 2022
-$2.0M-$1.0M0$1.0M2020: $505.0K$505.0K20202021: -$1.9M-$1.9M20212022: $0$02022−100%
Operating income756-$76.0M in 2022+135% since 2020
-$150.0M-$100.0M-$50.0M02020: -$32.3M-$32.3M20202021: -$125.1M-$125.1M2021+287%2022: -$76.0M-$76.0M2022−39%
Net income756-$75.2M in 2022+88% since 2020
-$150.0M-$100.0M-$50.0M02020: -$40.0M-$40.0M20202021: -$137.2M-$137.2M2021+243%2022: -$75.2M-$75.2M2022−45%
Fiscal year2019202020212022
Revenue$557.0K7$66.0K5$05
Cost of revenue$52.0K7$1.9M5$05
Gross profit$505.0K7-$1.9M5$05
Research and development$20.6M7$71.4M5$47.6M6
Operating expenses$123.2M5$76.0M6
Operating income-$32.3M7-$125.1M5-$76.0M6
Interest$1.2M7$840.0K5$514.0K6
Income before tax-$137.2M5-$75.2M6
Income tax$07$05$05
Net income-$40.0M7-$137.2M5-$75.2M6
Earnings per share-$1.795-$0.606
Earnings per share (diluted)-$1.795-$0.606
Shares (weighted, basic)76.6M shares5125.9M shares6
Shares (weighted, diluted)76.6M shares5125.9M shares6

Compare Vaxxinity, Inc. with another company

Leadership

Who has led Vaxxinity, Inc., and when. Pick a name to see everywhere that person has worked.

Chair

  1. Lou Reese2021–2022
2025
Board members and other officers (14)

Timeline

  1. Feb 2, 2021Founded Vaxxinity, Inc. is founded2

Filings

186 filings to the SEC since October 2021: 4 annual reports, 7 quarterly reports, 13 major events, 83 insider forms, 10 large holders, 69 other. The latest 20:

  1. May 9, 202415-12G EDGAR
  2. May 9, 2024DEF 14C EDGAR
  3. May 2, 2024EFFECT EDGAR
  4. Apr 30, 2024S-8 POS EDGAR
  5. Apr 30, 2024S-8 POS EDGAR
  6. Apr 30, 2024POS AM EDGAR
  7. Apr 29, 202410-K/A EDGAR
  8. Apr 29, 2024PRE 14C EDGAR
  9. Apr 29, 202425 EDGAR
  10. Apr 29, 20244 EDGAR
  11. Apr 19, 20248-K EDGAR
  12. Mar 27, 202410-K EDGAR
  13. Mar 14, 20248-K FORM 8K EDGAR
  14. Feb 15, 20248-K EDGAR
  15. Feb 12, 2024SC 13G/A EDGAR
  16. Feb 12, 2024SC 13G/A EDGAR
  17. Feb 7, 2024SC 13G/A EDGAR
  18. Dec 1, 20238-K EDGAR
  19. Nov 30, 2023144 EDGAR
  20. Nov 30, 2023144 EDGAR

The 186 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

38 open-market trades by officers, directors and large owners since October 2021: 25 buys and 13 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 8, 2023Prime Movers Lab Fund I LP10% ownerSale47,961$1.67$80.1KForm 4
Sep 7, 2023Prime Movers Lab Fund I LP10% ownerSale38,828$1.79$69.5KForm 4
Sep 6, 2023Prime Movers Lab Fund I LP10% ownerSale10,147$1.88$19.1KForm 4
Jan 23, 2023Sloss Dakin10% ownerSale500,692$3.35$1.7MForm 4
Dec 2, 2022Prime Movers Lab Fund I LP10% ownerSale13,741$2.57$35.3KForm 4
Dec 1, 2022Prime Movers Lab Fund I LP10% ownerSale334,807$2.97$994.4KForm 4
Sep 6, 2022Sloss Dakin10% ownerSale37,358$2.40$89.7KForm 4
Aug 25, 2022Prime Movers Lab Fund I LP10% ownerSale33,680$2.33$78.5KForm 4
Aug 24, 2022Prime Movers Lab Fund I LP10% ownerSale124,000$2.39$296.4KForm 4
Aug 23, 2022Prime Movers Lab Fund I LP10% ownerSale50,000$2.45$122.5KForm 4
Jun 16, 2022Reese LouSee RemarksBuy100,000$1.99$199.0KForm 4
Jun 16, 2022Hu Mei MeiSee RemarksBuy100,000$1.99$199.0KForm 4
Jun 16, 2022UNITED BIOMEDICAL INC10% ownerBuy100,000$1.99$199.0KForm 4
Jun 13, 2022Prime Movers Lab Fund I LP10% ownerSale137,000$2.43$332.9KForm 4
Jun 10, 2022Prime Movers Lab Fund I LP10% ownerSale42,000$2.80$117.6KForm 4
Jun 9, 2022UNITED BIOMEDICAL INC10% ownerBuy10,978$2.72$29.9KForm 4
Jun 9, 2022Hu Mei MeiSee RemarksBuy10,978$2.72$29.9KForm 4
Jun 9, 2022Reese LouSee RemarksBuy10,978$2.72$29.9KForm 4
Jun 8, 2022UNITED BIOMEDICAL INC10% ownerBuy10,000$2.95$29.5KForm 4
Jun 8, 2022Hu Mei MeiSee RemarksBuy10,000$2.95$29.5KForm 4

All 38 trades can be filtered by person here when JavaScript is on.

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28